€104.60
2.24% yesterday
Xetra, Apr 17, 05:35 pm CET
ISIN
DE000A2YNT30
Symbol
ACT
Index
Industry

Alzchem Group Target price 2025 - Analyst rating & recommendation

Alzchem Group Classifications & Recommendation:

Buy
100%

Alzchem Group Price Target

Target Price €102.38
Price €104.60
Deviation
Number of Estimates 5
5 Analysts have issued a price target Alzchem Group 2026 . The average Alzchem Group target price is €102.38. This is lower than the current stock price. The highest price target is
€120.00 14.72%
register free of charge
, the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend Alzchem Group to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alzchem Group stock has an average upside potential 2026 of . Most analysts recommend the Alzchem Group stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 554.23 581.34
2.51% 4.89%
EBITDA Margin 17.80% 19.58%
23.15% 10.00%
Net Margin 9.72% 10.15%
52.35% 4.37%

5 Analysts have issued a sales forecast Alzchem Group 2025 . The average Alzchem Group sales estimate is

€581m
Unlock
. This is
4.89% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€591m 6.60%
Unlock
, the lowest is
€572m 3.24%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €554m 2.51%
2025
€581m 4.89%
Unlock
2026
€624m 7.37%
Unlock
2027
€704m 12.79%
Unlock
2028
€743m 5.57%
Unlock
2029
€762m 2.54%
Unlock

5 Analysts have issued an Alzchem Group EBITDA forecast 2025. The average Alzchem Group EBITDA estimate is

€114m
Unlock
. This is
15.38% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€115m 16.27%
Unlock
, the lowest is
€113m 14.55%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €98.7m 26.25%
2025
€114m 15.38%
Unlock
2026
€128m 12.48%
Unlock
2027
€152m 18.90%
Unlock
2028
€169m 11.19%
Unlock
2029
€184m 8.48%
Unlock

EBITDA Margin

2024 17.80% 23.15%
2025
19.58% 10.00%
Unlock
2026
20.51% 4.75%
Unlock
2027
21.62% 5.41%
Unlock
2028
22.77% 5.32%
Unlock
2029
24.09% 5.80%
Unlock

3 Alzchem Group Analysts have issued a net profit forecast 2025. The average Alzchem Group net profit estimate is

€59.0m
Unlock
. This is
9.51% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€60.6m 12.51%
Unlock
, the lowest is
€57.6m 6.78%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €53.9m 56.18%
2025
€59.0m 9.51%
Unlock
2026
€66.0m 11.83%
Unlock
2027
€81.5m 23.48%
Unlock

Net Margin

2024 9.72% 52.35%
2025
10.15% 4.37%
Unlock
2026
10.57% 4.14%
Unlock
2027
11.58% 9.56%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 5.31 5.81
56.18% 9.42%
P/E 17.99
EV/Sales 1.80

3 Analysts have issued a Alzchem Group forecast for earnings per share. The average Alzchem Group EPS is

€5.81
Unlock
. This is
9.42% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€5.97 12.43%
Unlock
, the lowest is
€5.67 6.78%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €5.31 56.18%
2025
€5.81 9.42%
Unlock
2026
€6.50 11.88%
Unlock
2027
€8.03 23.54%
Unlock

P/E ratio

Current 19.68 53.99%
2025
17.99 8.59%
Unlock
2026
16.09 10.56%
Unlock
2027
13.03 19.02%
Unlock

Based on analysts' sales estimates for 2025, the Alzchem Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.89 110.00%
2025
1.80 4.52%
Unlock
2026
1.68 6.86%
Unlock
2027
1.49 11.34%
Unlock
2028
1.41 5.27%
Unlock
2029
1.38 2.47%
Unlock

P/S ratio

Current 1.92 134.37%
2025
1.83 4.66%
Unlock
2026
1.70 6.86%
Unlock
2027
1.51 11.33%
Unlock
2028
1.43 5.28%
Unlock
2029
1.39 2.47%
Unlock

Current Alzchem Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Mar 31 2025
WARBURG RESEARCH GMBH
Locked
Locked
Locked Mar 17 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Mar 06 2025
SPHENE CAPITAL GMBH
Locked
Locked
Locked Mar 02 2025
BERENBERG
Locked
Locked
Locked Dec 10 2024
WARBURG RESEARCH GMBH
Locked
Locked
Locked Nov 28 2024
SPHENE CAPITAL GMBH
Locked
Locked
Locked Nov 07 2024
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Mar 31 2025
Locked
WARBURG RESEARCH GMBH:
Locked
Locked
Mar 17 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Mar 06 2025
Locked
SPHENE CAPITAL GMBH:
Locked
Locked
Mar 02 2025
Locked
BERENBERG:
Locked
Locked
Dec 10 2024
Locked
WARBURG RESEARCH GMBH:
Locked
Locked
Nov 28 2024
Locked
SPHENE CAPITAL GMBH:
Locked
Locked
Nov 07 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today